한글목차

세계 일반의약품(OTC) 시장은 2019년 1,259억 654만 달러로 평가되었으며, 2024년까지 CAGR 4.00% 이상 성장했습니다.

R&D 투자 증가

연구개발에 대한 투자 증가는 역사적 기간 동안 일반의약품(OTC) 시장의 성장에 기여했습니다. 연구개발(R&D)에 대한 투자 증가는 셀프케어 치료의 기술 혁신을 촉진하여 일반의약품(OTC)의 성장을 촉진할 것입니다. 이러한 투자는 보다 효과적이고 안전한 표적 제제 개발, 약물전달 방법 개선, 규제 준수 강화에 기여하고 있습니다. 또한, R&D는 브랜드 차별화를 촉진하고, 시장 경쟁력을 강화하며, 과학적 근거가 있는 첨단 OTC 제품으로 소비자를 끌어들이고 있습니다. 예를 들어, 룩셈부르크에 본부를 둔 유럽연합(EU) 통계청 유로스타트(Eurostat)에 따르면 2023년 12월 EU의 연구개발(R&D) 지출은 2022년 3,520억 유로(3,844억 2,000만 달러)로 전년도 3,310억 유로(3,614억 8,000만 달러)에서 6.34% 증가했습니다. 이는 R&D 투자 증가가 일반의약품(OTC) 시장의 성장을 견인한 것으로 분석됩니다.

목차

제1장 주요 요약

• 일반의약품(OTC) - 시장 매력과 거시경제 상황

제2장 목차

제3장 표목차

제4장 그림목차

제5장 보고서 구성

제6장 시장 특징

• 일반적인 시장 정의
• 개요
• 일반의약품(OTC) 시장 정의와 세분화
• 시장 세분화 : 유형별
  • 기침, 감기, 인플루엔자 대책 제품
  • 진통제
  • 피부과 제품
  • 위장약
  • 비타민, 미네랄, 보충제(VMS)
  • 감량 또는 다이어트 제품
  • 안과용 제품
  • 수면 보조제
  • 기타 제품 유형
• 시장 세분화 : 제제 유형별
  • 정제
  • 액체
  • 연고
  • 스프레이
  • 기타 제제 유형
• 시장 세분화 : 유통 채널별
  • 병원 약국
  • 소매 약국
  • 온라인 약국
  • 기타 유통 채널
• 시장 세분화 : 최종사용자별
  • 전문 클리닉
  • 홈케어
  • 병원
  • 기타 최종사용자

제7장 주요 시장 동향

• 눈 알레르기 증상을 완화하는 생물학적 동등성 점안액 개발
• 발기부전 치료를 위한 혁신적인 속효성 OTC 젤
• 오피오이드 과잉 섭취 대책을 위한 적정 가격의 비강 스프레이 발매
• 혁신적인 시판 피임약이 더 많은 사람들에게 도달할 수 있도록
• 과식이나 과음으로 인한 설사를 억제하는 혁신적인 시판 피임약

제8장 일반용 의약품(OTC) 성장 분석과 전략 분석 프레임워크

• 세계의 일반의약품(OTC)에 관한 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인)
  • 정치적
  • 경제
  • 사회
  • 기술적
  • 환경
  • 법률상
• 최종사용자(B2B) 분석
  • 전문 클리닉
  • 홈케어
  • 병원
  • 기타 최종사용자
• 일반의약품(OTC) 시장 : 성장률 분석
• 시장 성장 실적, 2019-2024
  • 시장 성장 촉진요인 2019-2024년
  • 시장 성장 억제요인2019-2024년
• 시장 성장 예측, 2024-2029, 2034F
  • 시장 성장 촉진요인 2024-2029년
  • 시장 성장 억제요인 2024-2029년
• 성장 예측 기여 요인
  • 양적 성장 기여자
  • 성장 촉진요인
  • 성장 억제요인
• 일반의약품(OTC) 유효 시장 규모(TAM)

제9장 일반용 의약품(OTC) 시장 : 세분화

• 일반의약품(OTC) 시장 : 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장 : 제제 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 기침, 감기, 인플루엔자 대책 제품 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 진통제에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 피부과 제품에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 위장약에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 비타민, 미네랄, 보충제(VMS)에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 감량 또는 다이어트 제품에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 안과용 제품에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 수면 보조제에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장, 기타 제제 유형에 의한 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2029F, 2034F

제10장 일반용 의약품(OTC) 시장 : 지역·국가별 분석

• 일반의약품(OTC) 시장 : 지역별, 실적과 예측, 2019-2024, 2029F, 2034F
• 일반의약품(OTC) 시장 : 국가별, 실적과 예측, 2019-2024, 2029F, 2034F

제11장 아시아태평양 시장

제12장 서유럽 시장

제13장 동유럽 시장

제14장 북미 시장

제15장 남미 시장

제16장 중동 시장

제17장 아프리카 시장

제18장 경쟁 구도와 기업 개요

• 기업 개요
• Bayer AG
• Johnson & Johnson
• GlaxoSmithKline PLC
• Reckitt Benckiser Group PLC
• Sanofi S.A.

제19장 기타 주요 기업과 혁신적 기업

• Perrigo Company plc
• Haleon plc
• Teva Pharmaceutical Industries Ltd
• Dr. Reddy's Laboratories
• Cipla Ltd.
• Sun Pharmaceutical Industries Ltd
• Amneal Pharmaceuticals Inc.
• Abbott Laboratories
• Boehringer Ingelheim International GmbH
• Glenmark Therapeutics Ltd.
• Alkem Laboratories Ltd.
• Sonoma Pharmaceuticals Inc.
• Takeda Pharmaceutical Company Ltd
• Viatris(Mylan NV)
• AFT Pharmaceuticals Ltd.

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병

• Cooper Consumer Health Acquired Viatris Inc.
• Avista Healthcare Partners Acquired Trillium Healthcare Products
• Cipla South Africa Acquired Actor Pharma(Pty) Ltd.
• Glenmark Pharmaceuticals Inc. Acquired Wockhardt USA Inc.

제23장 일반용 의약품(OTC)의 최근 동향

• 변비 수요 증가를 겨냥한 시판용 완하제 신제품
• 빅데이터를 활용해 시판용 의약품으로의 원활한 전환을 실현
• 새로운 시판용 보충제로 산모의 건강과 영유아의 발달을 촉진

제24장 기회와 전략

• 일반의약품(OTC) 시장 2029 : 새로운 기회를 제공하는 국가
• 일반의약품(OTC) 시장 2029 : 새로운 기회를 제공하는 부문
• 일반의약품(OTC) 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제25장 일반용 의약품(OTC) 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

• 대상 지역
• 시장 데이터 소스
• 조사 방법
• 통화
• 비즈니스 조사 컨퍼니
• 저작권과 면책사항

영문목차

Over-the-counter (OTC) drugs are medications available for purchase without a prescription from a healthcare professional. They are designed for self-care, allowing individuals to manage common health issues such as headaches, colds, allergies and digestive problems.

The over the counter (OTC) drugs market consists of sales by entities (organizations, sole traders and partnerships) of over the counter (OTC) drugs that are typically used when symptoms are mild to moderate and do not require a doctor's intervention. OTC drugs often serve as the first line of treatment for minor ailments and can act as substitutes for prescription medications in certain situations. They are widely used across various settings, including homes, workplaces and while traveling, providing convenient relief from everyday health concerns.

The global over the counter (OTC) drugs market was valued at $125,906.54 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 4.00%.

Increasing Investment in Research And Development

The increasing investment in research and development contributed to the growth of the over-the-counter (OTC) drugs market in the historic period. The increasing investment in research and development (R&D) drives the growth of the over-the-counter (OTC) drug by driving innovation in self-care treatments. This investment has led to the development of more effective, safer and targeted formulations, improved drug delivery methods and enhanced regulatory compliance. Additionally, R&D fosters brand differentiation and strengthens market competitiveness, attracting consumers with advanced, science-backed OTC products. For instance, in December 2023, according to Eurostat, a Luxembourg-based statistical office of the European Union, the EU's expenditure on research and development (R&D) increased to €352 billion ($384.42 billion) in 2022, marking a 6.34% rise from €331 billion ($361.48) in the previous year. Therefore, increasing investment in research and development drove the growth of the over-the-counter (OTC) drugs market.

Development of Bioequivalent Ophthalmic Solution to Provide Eye Allergy Relief

Major companies operating in the over-the-counter (OTC) drugs market are focusing on the development of bioequivalent ophthalmic solutions to provide eye allergy relief. It offers the same therapeutic benefits at a potentially more competitive price, presenting an opportunity to drive revenue growth, expand its ophthalmic portfolio and solidify its position in the OTC pharmaceutical market. For instance, in March 2025, Glenmark Pharmaceuticals Inc., a US-based pharmaceutical company, received final approval from the U.S. Food and Drug Administration (FDA) for its olopatadine hydrochloride ophthalmic solution USP, 0.2% (OTC). This product is recognized as bioequivalent to Alcon Laboratories' Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC). Distribution in the U.S. will be managed by Glenmark Therapeutics Inc., USA. With the Pataday market generating approximately $50.7 million in annual sales, this approval presents a strategic growth opportunity for Glenmark to strengthen its ophthalmic portfolio and expand its presence in the over-the-counter eye care segment.

The global over the counter (OTC) drugs markets is fairly fragmented, with large number of players operating in the market. The top 10 competitors in the market made up 14.11% of the total market in 2023.

Over The Counter (OTC) Drugs Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global over the counter (OTC) drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for over the counter (OTC) drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The over the counter (OTC) drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider over the counter (OTC) drugs market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics:- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by formulation type, by distribution channel and by end user.
• Key Trends:- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis:- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Regional And Country Analysis:- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation:- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by formulation type, by distribution channel and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size And Growth:- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape:- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies:- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking:- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard:- Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions:- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments:- Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies:- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets
• Conclusions And Recommendations:- This section includes recommendations for over-the-counter (OTC) drugs market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
• Appendix:- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Cough, Cold And Flu Products; Analgesics; Dermatology Products; Gastrointestinal Products; Vitamins, Mineral And Supplements (VMS); Weight Loss Or Dietary Products; Ophthalmic Products; Sleeping Aids; Other Product Types
• 2) By Formulation Type: Tablets; Liquids; Ointments; Sprays; Other Formulation Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Channels
• 4) By End User: Specialty Clinics; Homecare; Hospitals; Other End Users
• Companies Mentioned: Bayer AG; Johnson & Johnson; GlaxoSmithKline PLC; Reckitt Benckiser Group PLC; Sanofi S.A.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; over the counter (OTC) drugs indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1.1 Over The Counter (OTC) Drugs - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Over The Counter (OTC) Drugs Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Cough, Cold and Flu Products
  • 6.4.2 Analgesics
  • 6.4.3 Dermatology Products
  • 6.4.4 Gastrointestinal Products
  • 6.4.5 Vitamins, Minerals and Supplements (VMS)
  • 6.4.6 Weight Loss or Dietary Products
  • 6.4.7 Ophthalmic Products
  • 6.4.8 Sleeping Aids
  • 6.4.9 Other Product Types
• 6.5 Market Segmentation By Formulation Type
  • 6.5.1 Tablets
  • 6.5.2 Liquids
  • 6.5.3 Ointments
  • 6.5.4 Sprays
  • 6.5.5 Other Formulation Types
• 6.6 Market Segmentation By Distribution Channel
  • 6.6.1 Hospital Pharmacies
  • 6.6.2 Retail Pharmacies
  • 6.6.3 Online Pharmacies
  • 6.6.4 Other Channels
• 6.7 Market Segmentation By End User
  • 6.7.1 Specialty Clinics
  • 6.7.2 Homecare
  • 6.7.3 Hospitals
  • 6.7.4 Other End Users

7 Major Market Trends

• 7.1 Development of Bioequivalent Ophthalmic Solution to Provide Eye Allergy Relief
• 7.2 Innovative Fast-Acting OTC Gels For Erectile Dysfunction Treatment
• 7.3 Launch of Affordable Nasal Spray to Combat Opioid Overdoses
• 7.4 Groundbreaking Over-the-Counter Birth Control Pill Offers Greater Access
• 7.5 Innovative OTC Drugs Targeting Diarrhea From Overeating And Overdrinking

8 Over The Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework

• 8.1 Global Over The Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End User (B2B)
  • 8.2.1 Specialty Clinics
  • 8.2.2 Homecare
  • 8.2.3 Hospitals
  • 8.2.4 Other End Users
• 8.3 Over The Counter (OTC) Drugs Market Growth Rate Analysis
• 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 8.4.1 Market Drivers 2019 - 2024
  • 8.4.2 Market Restraints 2019- 2024
• 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.5.1 Market Drivers 2024 - 2029
  • 8.5.2 Market Restraints 2024 - 2029
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Over The Counter (OTC) Drugs Total Addressable Market (TAM)

9 Over The Counter (OTC) Drugs Market Segmentation

• 9.1 Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.2 Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.3 Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.4 Over The Counter (OTC) Drugs Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.5 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Cough, Cold, And Flu Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.6 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Analgesics, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.7 Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Dermatology Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.8 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Gastrointestinal Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.9 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Vitamins, Mineral, And Supplements (VMS), By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.10 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Weight Loss Or Dietary Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.11 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Ophthalmic Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.12 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Sleeping Aids, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.13 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Other Product Types, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Over The Counter (OTC) Drugs Market, Regional and Country Analysis

• 10.1 Over The Counter (OTC) Drugs Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Over The Counter (OTC) Drugs Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.4 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.5 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.6 Asia-Pacific Over The Counter (OTC) Drugs Market: Country Analysis
• 11.7 China Market
• 11.8 Summary
• 11.9 Market Overview
  • 11.9.1 Country Information
  • 11.9.2 Market Information
  • 11.9.3 Background Information
  • 11.9.4 Government Initiatives
  • 11.9.5 Regulations
  • 11.9.6 Regulatory Bodies
  • 11.9.7 Major Associations
  • 11.9.8 Taxes Levied
  • 11.9.9 Corporate Tax Structure
  • 11.9.10 Investments
  • 11.9.11 Major Companies
• 11.10 China Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.11 China Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.12 China Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.13 India Market
• 11.14 India Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.15 India Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.16 India Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.17 Japan Market
• 11.18 Summary
• 11.19 Market Overview
  • 11.19.1 Country Information
  • 11.19.2 Market Information
  • 11.19.3 Background Information
  • 11.19.4 Government Initiatives
  • 11.19.5 Regulations
  • 11.19.6 Regulatory Bodies
  • 11.19.7 Major Associations
  • 11.19.8 Taxes Levied
  • 11.19.9 Corporate Tax Structure
  • 11.19.10 Investments
  • 11.19.11 Major Companies
• 11.20 Japan Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.21 Japan Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.22 Japan Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.23 Australia Market
• 11.24 Australia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.25 Australia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.26 Australia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.27 Indonesia Market
• 11.28 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.29 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.30 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.31 South Korea Market
• 11.32 Summary
• 11.33 Market Overview
  • 11.33.1 Country Information
  • 11.33.2 Market Information
  • 11.33.3 Background Information
  • 11.33.4 Government Initiatives
  • 11.33.5 Regulations
  • 11.33.6 Regulatory Bodies
  • 11.33.7 Major Associations
  • 11.33.8 Taxes Levied
  • 11.33.9 Corporate Tax Structure
  • 11.33.10 Investments
  • 11.33.11 Major Companies
• 11.34 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.35 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.36 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate tax structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.6 UK Market
• 12.7 UK Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.8 UK Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.9 UK Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 Germany Market
• 12.11 Germany Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.12 Germany Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 Germany Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 France Market
• 12.15 France Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.16 France Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 France Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 Italy Market
• 12.19 Italy Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.20 Italy Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.21 Italy Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 Spain Market
• 12.23 Spain Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.24 Spain Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 Spain Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major companies
• 13.3 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.6 Russia Market
• 13.7 Russia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.8 Russia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.9 Russia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 North America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 North America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.6 USA Market
• 14.7 Summary
• 14.8 Market Overview
  • 14.8.1 Country Information
  • 14.8.2 Market Information
  • 14.8.3 Background Information
  • 14.8.4 Government Initiatives
  • 14.8.5 Regulations
  • 14.8.6 Regulatory Bodies
  • 14.8.7 Major Associations
  • 14.8.8 Taxes Levied
  • 14.8.9 Corporate Tax Structure
  • 14.8.10 Investments
  • 14.8.11 Major Companies
• 14.9 USA Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.10 USA Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.11 USA Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.12 Canada Market
• 14.13 Summary
• 14.14 Market Overview
  • 14.14.1 Country Information
  • 14.14.2 Market Information
  • 14.14.3 Background Information
  • 14.14.4 Government Initiatives
  • 14.14.5 Regulations
  • 14.14.6 Regulatory Bodies
  • 14.14.7 Major Associations
  • 14.14.8 Taxes Levied
  • 14.14.9 Corporate Tax Structure
  • 14.14.10 Investments
  • 14.14.11 Major Companies
• 14.15 Canada Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.16 Canada Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.17 Canada Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 South America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 South America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 South America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.6 Brazil Market
• 15.7 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.8 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.9 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Africa Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Africa Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.5 Africa Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Bayer AG
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Business Strategy
  • 18.2.4 Financial Overview
• 18.3 Johnson & Johnson
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Financial Overview
• 18.4 GlaxoSmithKline PLC
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Financial Overview
• 18.5 Reckitt Benckiser Group PLC
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Business Strategy
  • 18.5.4 Financial Overview
• 18.6 Sanofi S.A.
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Financial Overview

19 Other Major And Innovative Companies

• 19.1 Perrigo Company plc
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 Haleon plc
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 Teva Pharmaceutical Industries Ltd
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 Dr. Reddy's Laboratories
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Cipla Ltd.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
• 19.6 Sun Pharmaceutical Industries Ltd
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
• 19.7 Amneal Pharmaceuticals Inc.
  • 19.7.1 Company Overview
  • 19.7.2 products And Services
• 19.8 Abbott Laboratories
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
• 19.9 Boehringer Ingelheim International GmbH
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
• 19.10 Glenmark Therapeutics Ltd.
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
• 19.11 Alkem Laboratories Ltd.
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
• 19.12 Sonoma Pharmaceuticals Inc.
  • 19.12.1 Company Overview
  • 19.12.2 Products And Services
• 19.13 Takeda Pharmaceutical Company Ltd
  • 19.13.1 Company Overview
  • 19.13.2 Products And Services
• 19.14 Viatris (Mylan NV)
  • 19.14.1 Company Overview
  • 19.14.2 Products And Services
• 19.15 AFT Pharmaceuticals Ltd.
  • 19.15.1 Company Overview
  • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Cooper Consumer Health Acquired Viatris Inc.
• 22.2 Avista Healthcare Partners Acquired Trillium Healthcare Products
• 22.3 Cipla South Africa Acquired Actor Pharma (Pty) Ltd.
• 22.4 Glenmark Pharmaceuticals Inc. Acquired Wockhardt USA Inc.

23 Recent Developments in Over The Counter (OTC) Drugs

• 23.1 New Over-the-Counter Laxative Targets Growing Constipation Demand
• 23.2 Leveraging Big Data for Seamless Transition to Over-the-Counter Medications
• 23.3 Enhancing Maternal Health and Infant Development with a New Over-the-Counter Supplement

24 Opportunities And Strategies

• 24.1 Over The Counter (OTC) Drugs Market In 2029 - Countries Offering Most New Opportunities
• 24.2 Over The Counter (OTC) Drugs Market In 2029 - Segments Offering Most New Opportunities
• 24.3 Over The Counter (OTC) Drugs Market In 2029 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Over The Counter (OTC) Drugs Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1.1 Geographies Covered
• 26.1.2 Market Data Sources
• 26.1.3 Research Methodology
• 26.1.4 Currencies
• 26.1.5 The Business Research Company
• 26.1.6 Copyright and Disclaimer